62 related articles for article (PubMed ID: 9592351)
1. [Detection of multidrug resistance in patients with leukemia by using flow cytometry and RNA in situ hybridization].
Li S; Wang C; Yao C
Zhonghua Nei Ke Za Zhi; 1996 Sep; 35(9):591-4. PubMed ID: 9592351
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemia.
Ross DD; Wooten PJ; Sridhara R; Ordóñez JV; Lee EJ; Schiffer CA
Blood; 1993 Aug; 82(4):1288-99. PubMed ID: 8102561
[TBL] [Abstract][Full Text] [Related]
3. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
4. Daunorubicin uptake by leukemic cells: correlations with treatment outcome and mdr1 expression.
Marie JP; Faussat-Suberville AM; Zhou D; Zittoun R
Leukemia; 1993 Jun; 7(6):825-31. PubMed ID: 8099135
[TBL] [Abstract][Full Text] [Related]
5. Phase I trial of high-dose tamoxifen as a modulator of drug resistance in combination with daunorubicin in patients with relapsed or refractory acute leukemia.
Berman E; McBride M; Lin S; Menedez-Botet C; Tong W
Leukemia; 1995 Oct; 9(10):1631-7. PubMed ID: 7564501
[TBL] [Abstract][Full Text] [Related]
6. Resistance of bcr-abl-positive acute lymphoblastic leukemia to daunorubicin is not mediated by mdr1 gene expression.
Gupta M; Kumar A; Dabadghao S
Am J Hematol; 2002 Nov; 71(3):172-6. PubMed ID: 12410571
[TBL] [Abstract][Full Text] [Related]
7. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
Maslak P; Hegewisch-Becker S; Godfrey L; Andreeff M
Cytometry; 1994 Sep; 17(1):84-93. PubMed ID: 8001461
[TBL] [Abstract][Full Text] [Related]
8. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
[TBL] [Abstract][Full Text] [Related]
9. Prolongation of medium exchange is associated with a decrease in function but not expression of the P-glycoprotein pump in leukaemic cells.
Hegewisch-Becker S; Faltz C; Hossfeld DK
Eur J Haematol; 1996; 56(1-2):12-22. PubMed ID: 8599988
[TBL] [Abstract][Full Text] [Related]
10. Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.
Efferth T; Sauerbrey A; Steinbach D; Gebhart E; Drexler HG; Miyachi H; Chitambar CR; Becker CM; Zintl F; Humeny A
Int J Oncol; 2003 Aug; 23(2):509-17. PubMed ID: 12851703
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies.
Van Acker KL; Van Hove LM; Boogaerts MA
Cytometry; 1993 Oct; 14(7):736-46. PubMed ID: 7902231
[TBL] [Abstract][Full Text] [Related]
12. [The relationship between multi-drug resistance gene expression and drug resistance of ovarian carcinoma].
Zhu L; Lang J; Shen K
Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):462-6. PubMed ID: 9639738
[TBL] [Abstract][Full Text] [Related]
13. Clinical approach to circumvention of multidrug resistance in refractory leukemic patients: association of cyclosporin A with etoposide.
Maia RC; Carriço MK; Klumb CE; Noronha H; Coelho AM; Vasconcelos FC; Ruimanek VM
J Exp Clin Cancer Res; 1997 Dec; 16(4):419-24. PubMed ID: 9505216
[TBL] [Abstract][Full Text] [Related]
14. Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia.
Dahl GV; Lacayo NJ; Brophy N; Dunussi-Joannopoulos K; Weinstein HJ; Chang M; Sikic BI; Arceci RJ
J Clin Oncol; 2000 May; 18(9):1867-75. PubMed ID: 10784627
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.
Li GY; Liu JZ; Zhang B; Wang LX; Wang CB; Chen SG
Biomed Pharmacother; 2009 Sep; 63(8):566-70. PubMed ID: 19095404
[TBL] [Abstract][Full Text] [Related]
16. [The clinical significance of MDR-1 gene expression in the hemopoietic cells of patients with acute leukemias in different phases of the disease].
Bykova TV; Sominskaia AA; Zaritskiĭ AIu; Stiuf IIu; Medvedeva BV; Anikina NA; Afanas'ev BV
Ter Arkh; 1998; 70(7):11-4. PubMed ID: 9742628
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of multidrug resistance gene(mdr1) expression in patients with acute leukemia].
Dong Z; Luo J; Xu W
Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):72-5. PubMed ID: 10743063
[TBL] [Abstract][Full Text] [Related]
18. Expression of the human multidrug resistance gene mdr1 in leukemic cells and its application in studying P-glycoprotein antagonists.
Fu J; Chen Z; Cen J; Ruan C
Chin Med J (Engl); 2000 Mar; 113(3):228-31. PubMed ID: 11775252
[TBL] [Abstract][Full Text] [Related]
19. [In vitro reversal effect of cyclosporin A in combination with cytokines on multidrug resistant cell line K562/A02].
Pu J; Lou F; Zhou Q
Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):224-6. PubMed ID: 11601045
[TBL] [Abstract][Full Text] [Related]
20. Establishment of a daunorubicin-resistant cell line which shows multi-drug resistance by multifactorial mechanisms.
Urasaki Y; Ueda T; Yoshida A; Fukushima T; Takeuchi N; Tsuruo T; Nakamura T
Anticancer Res; 1996; 16(2):709-14. PubMed ID: 8687117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]